Gesynta Pharma

Gesynta Pharma

Drug candidates with a unique mechanism of action, aiming to reduce inflammation and pain. Vipoglanstat to enter phase II for endometriosis.

HQ location
Stockholms kommun, Sweden
Website
Launch date
Employees
Enterprise value
$147—221m
Company register number
559103-6628
Authorizing premium user...